Remdesivir- Ivermectin Combination Therapy in Severe Covid-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Recent study reported in vitro synergistic interaction between two FDA approved drugs, remdesivir (RDV) and ivermectin (IVM) resulting in enhanced antiviral activity against SARS-CoV-2, the causative pathogen of COVID-19. The aim of the current study is comparing the efficacy and safety of combining remdesivir and ivermectin versus using remdesivir alone in patients with severe COVID-19.
Epistemonikos ID: 57d741cf8f32d0fd0a51e7b87c57a4d891d660f9
First added on: Jun 30, 2021